Caricamento...
Use of novel oral anticoagulant agents in venous thromboembolism
New oral anticoagulants (NOAC) serve as alternatives for patients currently using warfarin for the prevention and treatment of venous thromboembolic (VTE) disease. This article provides a brief summary of the clinical use of these drugs as well as a review of the landmark clinical trials which evalu...
Salvato in:
| Pubblicato in: | Cardiovasc Diagn Ther |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5220203/ https://ncbi.nlm.nih.gov/pubmed/28123977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt.2016.11.17 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|